VivoSeq
Other

Functional Endoscopic Sinus Surgery

0

Pipeline Programs

7

Active Trials

0

Companies Involved

Functional Endoscopic Sinus Surgery is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

6/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

18

clinical trials

Completed8 · 44%
Not yet recruiting3 · 17%
Recruiting2 · 11%
Unknown status2 · 11%
Active, not recruiting2 · 11%
Withdrawn1 · 6%

Trial Activity

18 trials

Functional Endoscopic Sinus Surgery Study
Active, not recruiting·UUniversity of Florida·Phase 1/2·NCT03970655·80 enrolled
Tranexamic Acid in Functional Endoscopic Sinus Surgery
Completed··Phase 4·NCT05686005·159 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)